Case File
efta-efta01049899DOJ Data Set 9OtherFrom: David Fiszel
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01049899
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: David Fiszel
To: Jeffrey
Jeffrey Epstein <[email protected]>
Subject: Honeycomb
Date: Sat, 26 May 2018 11:59:52 +0000
Jeffrey,
I hope you are doing great and have some fun plans this long weekend. I want to follow up on introducing
Honeycomb to some potential investors we discussed a few months ago.
Firstly, I'm grateful for your partnership. As my day one investor and co-investment partner no one has more
experience investing with Honeycomb and I need your help. Referrals is a very important way to grow our fund
since I'd rather be making money for us than hitting the road marketing to the Goldman cap intro list.
Our annualized returns are just under 15% net which I believe is what I told you to expect from me pre-launch.
We are working very hard and I want to hire more talent to uncover more oppty and further build upon our
success as we approach our second anniversary.
I will go anywhere at anytime to meet someone you say I should meet. Some updated stats - We are approx
$580m of assets, 10% my capital, 30% net return since inception, so we really haven't raised much outside
capital. I would like to take it to the next level with your help.
Just as an aside and i know it wouldn't change your life but I'm sure you know the fund of funds that come into
our 1.5/20 or 2/20 fee class actually charge an additional 50bps fees to investors that I don't see so perhaps there
is a business oppty for you as well. I want to grow to $2B by 2020.
Warmly,
David
This e-mail and any file(s) transmitted with it may contain confidential and/or privileged information. Nothing
contained in this e-mail and/or any file(s) transmitted with it constitutes a solicitation or an offer to buy or sell
any securities. Use or disclosure of this e-mail or any such files by anyone other than a designated addressee is
unauthorized. If you are not an intended recipient (or have received this email in error), please notify the sender
immediately and delete this e-mail without making a copy. If this e-mail is misdirected, Honeycomb Asset
Management, L.P. and its affiliates do not waive confidentiality or any privilege.
EFTA01049899
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Wire Ref
ReferralsRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.